Gilead Sciences (GILD) Shares Issued (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Shares Issued data on file, last reported at $166.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued fell 34.13% year-over-year to $166.0 million; the trailing twelve-month figure through Mar 2026 stood at $322.0 million (down 39.02% YoY), and the FY2025 full-year result was $408.0 million, down 3.32% from the prior year.
• Shares Issued for Q1 2026 stood at $166.0 million, up from $32.0 million in the prior quarter.
• Across five years, Shares Issued topped out at $252.0 million in Q1 2025 and bottomed at $3.0 million in Q2 2022.
• The 5-year median for Shares Issued is $94.0 million (2022), against an average of $90.4 million.
• The widest annual swing landed in 2022, when Shares Issued soared 1366.67%; it then sank 85.23% in 2023.
• A 5-year view of Shares Issued shows it stood at $176.0 million in 2022, then tumbled by 85.23% to $26.0 million in 2023, then surged by 565.38% to $173.0 million in 2024, then tumbled by 81.5% to $32.0 million in 2025, then jumped by 418.75% to $166.0 million in 2026.
• The last three Shares Issued figures came in at $166.0 million (Q1 2026), $32.0 million (Q4 2025), and $97.0 million (Q3 2025), per Business Quant data.

Peer Comparison